There are many studies that have looked at the relationship between the use of oral contraceptives and breast cancer risk. The results are not yet clear. This is due, in part, to the fact that the women who tend to take the contraceptives are unlikely to get breast cancer, so the numbers in the studies are low and hard to compare. A recent study did show that there is no link between use of oral contraceptives and survival of women who have breast cancer (http://www.ncbi.nlm.nih.gov/pubmed/21551244). Another recent study showed that IN COMBINATION with other factors, use of oral contraceptives may influence risk of breast cancer (http://www.ncbi.nlm.nih.gov/pubmed/21467202).
There are many studies that have looked at the relationship between the use of oral contraceptives and breast cancer risk. The results are not yet clear. This is due, in part, to the fact that the women who tend to take the contraceptives are unlikely to get breast cancer, so the numbers in the studies are low and hard to compare. A recent study did show that there is no link between use of oral contraceptives and survival of women who have breast cancer (http://www.ncbi.nlm.nih.gov/pubmed/21551244). Another recent study showed that IN COMBINATION with other factors, use of oral contraceptives may influence risk of breast cancer (http://www.ncbi.nlm.nih.gov/pubmed/21467202).
For pre-menopausal women with estrogen positive breast cancer, the hormonal treatment options are: - tamoxifen is the most common treatment - medications that temporarily stop the ovaries from producing estrogen are: Zoladex (goserelin acetate), Lupron (leuprolide), or Trelstar (triptorelin) - surgical removal of ovaries - radiation treatment to stop ovaries from working
A couple of less common treatments are Megace (megestrol) and Halotestin (fluoxymesterone). These treatments are used in specific cases.
For pre-menopausal women with estrogen positive breast cancer, the hormonal treatment options are: - tamoxifen is the most common treatment - medications that temporarily stop the ovaries from producing estrogen are: Zoladex (goserelin acetate), Lupron (leuprolide), or Trelstar (triptorelin) - surgical removal of ovaries - radiation treatment to stop ovaries from working
A couple of less common treatments are Megace (megestrol) and Halotestin (fluoxymesterone). These treatments are used in specific cases.
Call SHARE at: 866-891-2392
to speak directly to a trained breast cancer survivor for support and guidance.
3 Quick Ways You Can Help
1) Spread the word! Tell people you think might want some support. Tell medical professionals, health providers, and organizations.
2) Like us on Facebook and follow us on Twitter! 3) Volunteer - email us at volunteer@talkabouthealth.com for more information.
- tamoxifen is the most common treatment
- medications that temporarily stop the ovaries from producing estrogen are: Zoladex (goserelin acetate), Lupron (leuprolide), or Trelstar (triptorelin)
- surgical removal of ovaries
- radiation treatment to stop ovaries from working
A couple of less common treatments are Megace (megestrol) and Halotestin (fluoxymesterone). These treatments are used in specific cases. For pre-menopausal women with estrogen positive breast cancer, the hormonal treatment options are:
- tamoxifen is the most common treatment
- medications that temporarily stop the ovaries from producing estrogen are: Zoladex (goserelin acetate), Lupron (leuprolide), or Trelstar (triptorelin)
- surgical removal of ovaries
- radiation treatment to stop ovaries from working
A couple of less common treatments are Megace (megestrol) and Halotestin (fluoxymesterone). These treatments are used in specific cases.
Note: Usernames have been made anonymous and profile images are not shown to protect the privacy of our members.